2009-10
- Received WHO Good Manufacturing Practices certificate for Derabassi facility
- Accredited by ISO-14001-2004 for Environmental Management
- Commissioned new Custom Synthesis and R&D Centre at HSIIDC , Barwala,Haryana
- Draft Red Herring Prospectus filed for the company's Initial Public Offer
- Adapted a customized ERP system for enhancing productivity
- Filed six DMFs in the US and EU
- Addition of 6 new Cephalosporin APIs in the product basket
2008-09
- Diversified into Custom Synthesis for Innovator Companies
- Expanded the product basket with Sterile Cephalosporin API capacities
- Commissioned two plants for additional Cephalosporin APIs
- Eight DMFs filed
- Registered presence in 39 countries
2007-08
- Diversified into Cephalosporins
- Filed three DMFs in US
- Established a Sterile Facility
- R&D Wing commissioned
2005-06
- Filed COS for two Penicillin APIs in the EU
2003-05
- Commenced Commercial Operations of PDL II at Panchkula
2000-02
- Commenced Contract Manufacturing for DSM and Ranbaxy.
1997-98
- Commenced Commercial Operations of PDL-I at Derabassi for Penicillin API and API Intermediates